1256387-87-7Relevant articles and documents
Method for recycling precious metal catalyst in preparation process of intermediate (by machine translation)
-
Paragraph 0012-0018, (2019/08/06)
The invention relates to a recovery method, in particular to a recovery method of a precious metal catalyst in a preparation process of a. The method comprises the following steps a, reacting compound 1, bisboronic acid pinacol, catalyst bis (di-t-butylphenylphosphine) palladium dichloride (II), potassium carbonate and stirring to tetrahydrofuran, and then 50 - 60 °C filtering the reaction liquid to remove residual potassium carbonate, adding an organic solvent after concentrating the filtrate, and cooling the residue 60 - 70 °C unitarily and centrifu, 5 - 6 hours after concentrating the filtrate 20 - 30 °C into an organic solvent, and adding the organic solvent. The compound 2; b, the remaining mother liquor after the centrifugation is collected and concentrated to dryness, and the crude 5-fold tetrahydrofuran, di-tert-butylphenylphosphine and auxiliary, 50 - 65 °C which are 1 - 2 hours concentrated, are added to obtain the catalyst bis (di-tert-butylphenylphosphine) dipalladium (II). The preparation process is simple, the reaction yield is high, the production cost is greatly reduced, and the method is suitable for industrial production. (by machine translation)
Preparation method for ledipasvir impurities
-
Paragraph 0033; 0050-0051, (2017/05/17)
The invention provides a preparation method for ledipasvir impurities, belonging to the technical field of pharmaceutical technology. The method comprises the following steps: subjecting a raw material, i.e., a compound 1, and N-fluoro-N-(benzenesulfonyl)benzsulfamide to a substitution reaction in the presence of lithium hexamethyldisilazide so as to prepare a compound 2; and further preparing the ledipasvir impurities like a target compound 5 and a target compound 10 from the compound 2. The method provided by the invention has the advantages of simplicity, high efficiency, economic performance and the like and is suitable for industrialization.
9,9,10,10-TETRAFLUORO-9,10-DIHYDROPHENANTHRENE HEPATITIS C VIRUS INHIBITOR AND APPLICATION THEREOF
-
Paragraph 0134-0136; 0259-0262, (2016/10/31)
The present invention belongs to the field of chemical pharmaceuticals, and specifically relates to compounds represented by formula I having a 9,9,10,10-tetrafluoro-9,10-dihydrophenanthrene structure and being able to inhibit hepatitis C virus activity, or a pharmaceutically acceptable salt, isomer, solvate, crystal or prodrug of said compounds, a pharmaceutical composition containing said compounds, and an application of said compounds or composition in the preparation of a drug. The compounds of the present invention have a good HCV inhibitory effect.